Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Clinical trial NCT02230618 · COMPLETED

Trial details

NCT number

NCT02230618

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Study type

OBSERVATIONAL

Start date

2015-11-24

Primary completion

2017-06-01

Enrollment

1029

View on ClinicalTrials.gov